arrow
H

Hinta Meijerink

norwegian institute of public health
H指数:19
被引数:1,546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of ongoing pregnancies using routine ultrasound procedure codes for timely surveillance of maternal vaccine uptake: A Norwegian registry study

通过常规超声程序代码识别持续性妊娠,以进行及时监测母体疫苗接种情况:一项挪威登记研究

2026-07-300
PRE
Unmeasured confounding and misclassification in studies estimating vaccine effectiveness against hospitalisation and death using electronic health records (EHRs): an evaluation of a multi-country European retrospective cohort study

未测量混杂和错分偏倚在利用电子健康记录(EHRs)评估疫苗对住院和死亡的保护效果研究中的影响:一项多国欧洲回顾性队列研究的评估

2025-12-170
OAAI
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23

2022/23年度在VEBIS-EHR网络中针对秋季加强针的两种COVID-19疫苗有效性估计方法的比较

2025-03-172
OAAI
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
2024-11-251
OA
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study
2024-09-018
PRE
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study

10月2023年11月,XBB.1.5单价新型冠状病毒肺炎疫苗在欧盟/欧洲经济区国家XBB.1.5主导时期的有效性: vebis-ehr网络研究

2024-04-233
OA
COVID-19 Vaccine Effectiveness Among Adolescents
2024-01-103
PRE
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023

≥ 65岁人群新型冠状病毒肺炎住院的相对疫苗有效性: 欧洲VEBIS网络的结果,2021年10月2023年7月

2024-01-041
OAAI
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022

2021年10月2022年11月,在六个欧洲国家使用电子健康登记处监测新型冠状病毒肺炎疫苗对新型冠状病毒肺炎住院和死亡的有效性

2023-11-282
OAAI
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses

在北欧国家omicron占主导地位期间,针对严重新型冠状病毒肺炎的异源第三剂量疫苗方案的比较有效性: 基于人群的队列分析

2023-07-2416
OAAI
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021

挪威成年人对SARS-CoV-2感染和住院治疗的年龄和产品依赖性疫苗有效性: 一项2021年7月到11月的国家队列研究

2022-09-0224
OAAI
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
2022-07-289
OAAI
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021

2020年12月2021年11月,世卫组织欧洲区域因新型冠状病毒肺炎疫苗接种而直接避免的60岁及以上人群死亡估计数

2021-11-2590
OAAI
The First GAEN-Based COVID-19 Contact Tracing App in Norway Identifies 80% of Close Contacts in Real Life Scenarios

挪威第一个基于GAEN的新型冠状病毒肺炎联系人追踪应用程序在现实生活中确定了80% 位密切联系人

2021-11-175
OAAI